- GlobeNewswire•18 days ago
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in Luxembourg
The national marketing approval in Luxembourg completes the current approval process of RIZAPORT ® under the European Decentralized Procedure; RIZAPORT ® is also approved for marketing in Germany and a ...
- Marketwired•18 days ago
IntelGenx and RedHill Biopharma Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
SAINT LAURENT, QUEBEC-- - The national marketing approval in Luxembourg completes the current approval process of RIZAPORT® under the European Decentralized Procedure ; RIZAPORT® is also approved for marketing ...
- Marketwired•25 days ago
IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of Convertible Unsecured Debentures
IntelGenx Technologies Corp. is pleased to announce that it has filed a preliminary short form prospectus with respect to an offering of a minimum of Cdn$7,000,000 and a maximum of Cdn$10,000,000 aggregate ...
IGX.V : Summary for INTELGENX TECHNOLOGIES CORP. - Yahoo Finance
IntelGenx Technologies Corp. (IGX.V)
TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.92 - 0.93|
|52 Week Range||0.61 - 1.35|
|PE Ratio (TTM)||-46.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|